Home / Filing changes / MCK
Free · no account · quoted from the filing
What changed in MCK's 10-K
Source: 10-K filed 2026-05-08 · compared against 10-K 2025-05-09. Every passage below is quoted verbatim from the filing itself.
Healthcare Regulation
This filing
Executive Order 14297 ... seeks to facilitate manufacturers’ sale of certain drugs in the U.S. at no higher than the lowest prices paid in other developed countries.
340B Drug Pricing Program
This filing
HRSA continues to evaluate the potential implementation of a retrospective rebate model to effectuate 340B pricing in lieu of upfront discounts.
ACA Subsidies
This filing
The ACA’s enhanced premium subsidies expired on December 31, 2025, and remain subject to ongoing Congressional review.
AI Regulation
This filing
AI laws and guidance are rapidly expanding and changing, with potential differences or conflicts across jurisdictions.
Antitrust Laws
This filing
laws may be proposed to restrict certain healthcare ownership structures or arrangements, such as vertical integration involving physician practice administrative or management services
What it means — the analyst reading
The passages above are the company's own words. The plain-English reading of them — what changed, why it matters, and the direction of travel, plus 1 further change without a quotable passage — is part of the Filing Change Monitor.
See the Filing Change Monitor →Compared from narrative excerpts (outlook, risks, MD&A) of both filings — quotes are verbatim from the new filing. Not advice. Source: company SEC filings via stockportfolio.pro. Educational, not investment advice.